MLICM
ASRT

Metropolitan Life Insurance Company (MetLife)’s Assertio ASRT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ASRT Stock Details ASRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-327
Closed -$12.6K – 2346
2023
Q3 		$12.6K Buy
327
+125
+62% +$7.3K ﹤0.01% 2114
2023
Q2 		$16.4K Buy
+202
New +$18.8K ﹤0.01% 2034
2019
Q3 		– Sell
-365
Closed -$75.5K – 2576
2019
Q2 		$75.5K Buy
365
+93
+34% +$22.1K ﹤0.01% 2438
2019
Q1 		$82.8K Sell
272
-63
-19% -$16.3K ﹤0.01% 2420
2018
Q4 		$72.6K Hold
335
– – ﹤0.01% 2469
2018
Q3 		$118K Hold
335
– – ﹤0.01% 2352
2018
Q2 		$134K Hold
335
– – ﹤0.01% 2173
2018
Q1 		$133K Hold
335
– – ﹤0.01% 2142
2017
Q4 		$162K Sell
335
-374
-53% -$145K ﹤0.01% 2027
2017
Q3 		$246K Sell
709
-38
-5% -$17.9K ﹤0.01% 2161
2017
Q2 		$482K Hold
747
– – ﹤0.01% 1720
2017
Q1 		$563K Hold
747
– – ﹤0.01% 1571
2016
Q4 		$808K Sell
747
-20
-3% -$25.5K 0.01% 1414
2016
Q3 		$1.15M Hold
767
– – 0.01% 1204
2016
Q2 		$903K Sell
767
-6
-0.8% -$6.56K 0.01% 1317
2016
Q1 		$646K Buy
773
+12
+2% +$11.1K 0.01% 1428
2015
Q4 		$828K Buy
761
+77
+11% +$86.6K 0.01% 1283
2015
Q3 		$774K Hold
684
– – 0.01% 1329
2015
Q2 		$881K Sell
684
-41
-6% -$56.2K 0.01% 1371
2015
Q1 		$975K Sell
725
-70
-9% -$86.2K 0.01% 1206
2014
Q4 		$769K Hold
795
– – 0.01% 1493
2014
Q3 		$725K Sell
795
-10
-1% -$8.03K 0.01% 1475
2014
Q2 		$672K Hold
805
– – ﹤0.01% 1619
2014
Q1 		$701K Hold
805
– – ﹤0.01% 1580
2013
Q4 		$511K Hold
805
– – ﹤0.01% 1804
2013
Q3 		$361K Hold
805
– – ﹤0.01% 1977
2013
Q2 		$271K Buy
+805
New +$269K ﹤0.01% 2123

Other funds holding ASRT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ASRT Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Assertio (ASRT) in Q4 2023, closing a stake of 327 shares — an estimated $12.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ASRT in Q2 2013 and held it in 27 quarters. The position peaked at $1.15M in Q3 2016. 115 funds tracked by Wall St. Rank hold ASRT as of Q4 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Assertio position as of Q4 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 327 Assertio shares in Q4 2023, an estimated $12.6K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Assertio in Q2 2013 and held it in 27 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Assertio position peaked at $1.15M in Q3 2016.
  • 115 funds tracked by Wall St. Rank held Assertio as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.